---
title: "Eliquis (apixaban) in nonvalvular atrial fibrillation: Pharmacology questions"
description: "Pharmacology questions on Eliquis (apixaban) in nonvalvular atrial fibrillation, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Mechanism, Pharmacokinetics, and Components. Questions: How does Eliquis work (mechanism of action)? How is Eliquis metabolized and eliminated? What are the inactive ingredients in Eliquis tablets? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/pharmacology"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Eliquis (apixaban) in nonvalvular atrial fibrillation: Pharmacology questions

Manufacturer: Bristol-Myers Squibb Company; Pfizer Inc  
Prescribing information: [Eliquis](https://packageinserts.bms.com/pi/pi_eliquis.pdf)

## Mechanism

<a id="eliquis-mechanism"></a>

### How does Eliquis work (mechanism of action)?

> “Apixaban is a selective inhibitor of FXa. It does not require antithrombin III for antithrombotic 
> activity. Apixaban inhibits free and clot-bound FXa, and prothrombinase activity. Apixaban has 
> no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced 
> by thrombin. By inhibiting FXa, apixaban decreases thrombin generation and thrombus 
> development.”

Source: [ELIQUIS: Prescribing information, page 8, captured 2026-11-12](https://packageinserts.bms.com/pi/pi_eliquis.pdf#page=8)

## Pharmacokinetics

<a id="eliquis-metabolism"></a>

### How is Eliquis metabolized and eliminated?

> “Metabolism
> Approximately 25% of an orally administered apixaban dose is recovered in urine and feces as 
> metabolites. Apixaban is metabolized mainly via CYP3A4 with minor contributions from CYP1A2, 
> 2C8, 2C9, 2C19, and 2J2. O-demethylation and hydroxylation at the 3-oxopiperidinyl moiety are 
> the major sites of biotransformation.
> Unchanged apixaban is the major drug-related component in human plasma; there are no 
> active circulating metabolites.”

Source: [ELIQUIS: Prescribing information, page 8, captured 2026-11-12](https://packageinserts.bms.com/pi/pi_eliquis.pdf#page=8)

> “Elimination
> Apixaban is eliminated in both urine and feces. Renal excretion accounts for about 27% of 
> total clearance. Biliary and direct intestinal excretion contributes to elimination of apixaban 
> in the feces.”

Source: [ELIQUIS: Prescribing information, page 8, captured 2026-11-12](https://packageinserts.bms.com/pi/pi_eliquis.pdf#page=8)

## Components

<a id="eliquis-inactive-ingredients"></a>

### What are the inactive ingredients in Eliquis tablets?

> “ELIQUIS tablets 2.5 mg and 5 mg are available for oral administration and contain the following 
> inactive ingredients: anhydrous lactose, microcrystalline cellulose, croscarmellose sodium, 
> sodium lauryl sulfate, and magnesium stearate. The film coating contains lactose monohydrate, 
> hypromellose, titanium dioxide, triacetin, and yellow iron oxide (2.5 mg tablets) or red iron oxide 
> (5 mg tablets).”

Source: [ELIQUIS: Prescribing information, page 8, captured 2026-11-12](https://packageinserts.bms.com/pi/pi_eliquis.pdf#page=8)

## Related pages
- [Medical information: Eliquis (apixaban): Nonvalvular atrial fibrillation](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation)
- [Indication](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/safety)
- [Specific populations](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/eliquis--nonvalvular-atrial-fibrillation/access-and-coverage)
